S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
What to Expect from the Markets in a Recession
China July exports rise, with trade surplus at record-high
What's in Democrats' big bill? Climate, health care, savings
Shift in war's front seen as ships cleared to leave Ukraine
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
NYSE:ABBV

AbbVie (ABBV) SEC Filings & 10K Form

$138.04
-0.88 (-0.63%)
(As of 08/5/2022 08:48 PM ET)
Add
Compare
Today's Range
$137.95
$139.91
50-Day Range
$137.62
$154.14
52-Week Range
$105.56
$175.91
Volume
5.37 million shs
Average Volume
7.31 million shs
Market Capitalization
$243.93 billion
P/E Ratio
19.55
Dividend Yield
4.09%
Price Target
$160.50

Recent AbbVie SEC Filings

DateFilerForm TypeView
07/29/2022
6:49 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2022
12:11 PM
AbbVie (Issuer)
Reents Scott T (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/06/2022
3:17 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2022
4:25 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/29/2022
7:30 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2022
8:16 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/23/2022
4:07 PM
AbbVie (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/23/2022
4:06 PM
AbbVie (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
05/31/2022
4:01 PM
AbbVie (Filer)
Form SD
Specialized Disclosure Report  
05/25/2022
3:58 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2022
4:03 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4/A
05/18/2022
4:12 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/13/2022
4:46 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2022
4:06 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2022
4:05 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:15 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:14 PM
AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:14 PM
AbbVie (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:13 PM
AbbVie (Issuer)
Roberts Rebecca B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:13 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:13 PM
AbbVie (Issuer)
MEYER MELODY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:12 PM
AbbVie (Issuer)
Hart Brett J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:11 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:10 PM
AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:10 PM
AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2022
4:09 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2022
11:51 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2022
8:00 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2022
6:45 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2022
4:12 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2022
8:15 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/25/2021
5:08 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/25/2021
5:08 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
12:05 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/02/2021
12:28 PM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2021
6:52 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2021
4:20 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2021
4:12 PM
AbbVie (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/11/2021
4:07 PM
AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:07 PM
AbbVie (Issuer)
TILTON GLENN F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:07 PM
AbbVie (Issuer)
Roberts Rebecca B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
MEYER MELODY B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
Hart Brett J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:06 PM
AbbVie (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2021
4:05 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/07/2021
9:14 AM
AbbVie (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2021
2:39 PM
AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
Form 25-NSE
04/30/2021
6:44 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/20/2021
7:30 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2021
12:10 PM
AbbVie (Subject)
ZEVIN ASSET MANAGEMENT LLC (Filed by)
Form PX14A6G
04/01/2021
3:43 PM
AbbVie (Issuer)
Alpern Robert J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
3:43 PM
AbbVie (Issuer)
LIDDY EDWARD M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2021
3:43 PM
AbbVie (Issuer)
RAPP EDWARD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2021
1:18 PM
AbbVie (Subject)
Rhode Island Employees Retirement System Pool Trust (Filed by)
Form PX14A6G
03/29/2021
9:56 AM
AbbVie (Subject)
Chevedden John (Filed by)
Form PX14A6G
03/22/2021
4:03 PM
AbbVie (Filer)
Form DEFA14A
03/12/2021
4:02 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/09/2021
4:26 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2021
4:27 PM
AbbVie (Filer)
Form PRE 14A
03/02/2021
7:34 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:32 PM
AbbVie (Issuer)
Michael Robert A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:31 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:31 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:30 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:29 PM
AbbVie (Issuer)
Durkin Brian L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:29 PM
AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:27 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:26 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:26 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:25 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/02/2021
7:25 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2021
5:28 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:25 PM
AbbVie (Issuer)
Gosebruch Henry O (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:25 PM
AbbVie (Issuer)
Michael Robert A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:23 PM
AbbVie (Issuer)
SEVERINO MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:19 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:19 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:18 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:17 PM
AbbVie (Issuer)
Hudson Thomas J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:17 PM
AbbVie (Issuer)
Sorg Elaine K. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:16 PM
AbbVie (Issuer)
Strom Carrie C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
5:15 PM
AbbVie (Issuer)
Durkin Brian L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2021
1:05 PM
AbbVie (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/16/2021
2:46 PM
AbbVie (Subject)
Capital Research Global Investors (Filed by)
Form SC 13G/A
02/03/2021
6:41 AM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2021
3:30 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2021
4:00 PM
AbbVie (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2020
12:15 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
12:14 PM
AbbVie (Issuer)
Schumacher Laura J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/31/2020
12:13 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:34 PM
AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2020
3:31 PM
AbbVie (Issuer)
Stewart Jeffrey Ryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2020
4:22 PM
AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NYSE:ABBV) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.